Our Medical protective coverall and Isolation gown is well know brand and there composed of the high gram-weight composite nonwoven material with the seams covered with special hot sealing tape. The coating can isolate virus-containing aero gel and liquid. When take off the protective coverall There are exported USA and Europe.
Gods Navi Gloves - nitrile medical examination gloves from Vietnam. This production line offers ten million boxes (100 cte) per month (2.5 million per week) over a period of 12 months +. INCO - CIF 100% LC.
All docs in hand including full chain of custody to manufacturer.
510K
FDA
EU
Health Canada
Price: $8.25 USD
INCO: CIF
Payment: 100% LC
MOQ: 120 Million boxes over 13 months production cycle
First shipment within 30 days of fully executed SPA.
2266 Miscellaneous Suppliers
Short on time? Let Miscellaneous sellers contact you.
Made in Canada
Health Canada approved
CE Mark and ISO certified
The product has proven to have 100% Specificity and 96% Sensitivety
Stock availabity: 2 Million tests/kit in Canada
Production: up to 5 Million tests/kit weekly
The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is authorized for use at the Point of Care i.e., in patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patientâ??s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The Rapid Responseâ?¢ COVID-19 Antigen Rapid Test Device is for use at the Point of Care for professional use only.
PRODUCT INFORMATION:
Product: Rapid Respose
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit per box
Time to result: 15 minutes
Storage Condition: 2-30 C/36-86 F
Test Principle: Immunochromatographic Assay
CONTENTS - Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
Canadian ASTM Face Masks
- Meets ASTM Level 3 F2100-19 Standard
- Designed, manufactured, packaged in Ontario, Canada
- Made in an ISO-8 Clean Room Facility
- Each Box is Individually Shrink Wrapped
- 50 Masks per Box
